Atlas Trials

Leptomeningeal Disease

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Leptomeningeal Disease

RecordFirmDate
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis (NCT06417710)University of Zurich2022-01-30
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) (NCT05112549)University Hospital Tuebingen2021-10-12
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease (NCT04588545)H. Lee Moffitt Cancer Center and Research Institute2020-12-10
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease (NCT03719768)H. Lee Moffitt Cancer Center and Research Institute2019-06-10
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD (NCT03501979)University of Alabama at Birmingham2019-02-20
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC (NCT03711422)National Cancer Centre, Singapore2018-11-16
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis (NCT02422641)Wake Forest University Health Sciences2015-05-01

Track Leptomeningeal Disease automatically

Every clearance here is in the API, with alerts when new ones post.